Why the study?
Does age ≥80 years reduce the likelihood of oral anticoagulant prescription for secondary stroke prevention in patients with atrial fibrillation?
Population
152 patients with atrial fibrillation hospitalized for first-ever ischemic stroke
Comparison
Oral anticoagulant (OAC) prescription at discharge vs Patients aged <80 years
Design
Cohort
Authors
Loading...
Age-related OAC underuse after stroke in AF warrants prescribing caution; leaves open whether frailty or bias drives decisions in octogenarians.
Does age ≥80 years reduce the likelihood of oral anticoagulant prescription for secondary stroke prevention in patients with atrial fibrillation?
Oral anticoagulants are significantly underprescribed for secondary stroke prevention in very elderly (≥80 years) patients with atrial fibrillation despite proven efficacy.
Lin et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: